Development of an Improved Epstein-Barr Virus (EBV) Neutralizing Antibody Assay to Facilitate Development of a Prophylactic gp350-Subunit EBV Vaccine.
Mediterr J Hematol Infect Dis. 2020 Mar 1;12(1):e2020016. doi: 10.4084/MJHID.2020.016. eCollection 2020.
Mediterr J Hematol Infect Dis. 2020.
PMID: 32180911
Free PMC article.